Women - PowerPoint PPT Presentation

About This Presentation
Title:

Women

Description:

Women s Health and the Media: Where do we find trustworthy information? – PowerPoint PPT presentation

Number of Views:216
Avg rating:3.0/5.0
Slides: 90
Provided by: JudyN151
Learn more at: https://www2.gwu.edu
Category:

less

Transcript and Presenter's Notes

Title: Women


1
  • Womens Health and the Media
  • Where do we find trustworthy information?

2
  • What are the key challenges?
  • Media portrayals of new medical research often
    inaccurate
  • A societal embracing of the quick fix or pill
    for every ill approach

3
  • Key Challenges.
  • Increasing influence of the pharmaceutical
    industry over physician prescribing practices as
    well as the educational and advertising materials
    aimed at the consumer or patient

4
  • Amidst the plethora of websites, ads and other
    sources, how does one find trustworthy
    information?

5
  • Know the source of your information and look out
    for conflicts of interest
  • Utilize non-commercial websites prepared by those
    who know how to evaluate the quality of the
    research that they cite
  • Use more than one source

6
  • EXAMPLE OF CHILDBIRTH AND THE RISING CESAREAN
    SECTION RATES IN THE UNITED STATES

7
Reasons for Rising Cesarean Rates(IOM 1989
report)
  • 30 of the rise due to diagnosis of dystocia
    (abnormal or difficult labor)
  • 25-30 due to repeat cesarean section
  • 10-25 due to breech presentation
  • 10-15 due to fetal distress

8
Current reasons for rising cesarean rates
  • Primarily changes in obstetrical practice, such
    as
  • - More repeat cesareans
  • - More refusals to allow VBACs
  • - Concerns about malpractice
  • - More advocates of medically- unnecessary
    cesareans

9
  • NCHS TRACKING IN 2004
  • Cesarean delivery rate rose 6 percent in 2004 to
    29.1 percent of all births, the highest rate ever
    reported in the United States
  • From http//www.cdc.gov/nchs/products/pubs/pubd/h
    estats/prelimbirths04/prelimbirths04health.htm

10
TRACKING in 2004 (cont.)The rate has
increased by over 40 percent since 1996. For
200304 the primary cesarean rate rose 8 percent,
and the rate of vaginal birth after cesarean
delivery (VBAC) dropped 13 percent. The primary
rate has climbed 41 percent and the VBAC rate has
fallen 67 percent since 1996.
11
NIH Meetingon Cesareans by Maternal Request
(March 27-29, 2006)Will media coverage of this
meeting and its report result in more cesareans
with no medical indication (elective surgery)?
12
  • QUESTIONS ADDRESSED AT THE NIH MEETING
  • What is the trend and incidence of cesarean
    delivery in the US and other countries?
  • What are the benefits and harms of cesarean by
    request vs. attempted vaginal birth (both
    short-term and long-term)?
    (Cont.)

13
QUESTIONS (cont.)
  • What factors influence benefits and harms?
  • What research should be done to get better
    evidence for making decisions regarding cesarean
    delivery on request vs. attempted vaginal
    delivery?

14
Panels RecommendationsFinal report at
www.consensus.nih.gov/2006
  • Insufficient evidence, so more research needed on
    benefits and risks of cesarean delivery on
    maternal request vs. planned vaginal delivery
  • Until better evidence is available, any decision
    to do cesareans upon maternal request should be
    carefully considered

15
Recommendations (cont.)
  • Not recommended for women desiring several
    children given rising risks of placenta previa
    and accreta with each cesarean delivery
  • No cesareans upon maternal request prior to 39
    weeks or without verification of lung maturity
    (because of significant risks of neonatal
    respiratory complications)

16
Recommendations (cont.)
  • Effective pain management services should be
    available for all women so that fear of pain is
    not a motivating factor for an elective cesarean
  • NIH (or other appropriate Federal agency)
    establish a website with up-to-date information

17
  • The final report did not adequately consider
    many recognized long-term adverse outcomes
    associated with cesarean surgery and did not take
    into account the impact that avoidable obstetric
    practices can cause during vaginal birth.

18
  • From the national Listening to Mothers II Survey
    of the Childbirth Connection in NYC
    (http//www.childbirthconnection.org/article.asp?c
    k10401)
  • 56 of women who wanted a vaginal birth after
    having had a cesarean said a doctor denied them
    that option.
  • 1 out of every 4 women polled who had caesarean
    said they felt pushed into having the surgery.

19
Excellent discussions of this meeting
  • Diony Youngs editorial in the September 2006
    issue of BIRTH Cesarean Delivery on Maternal
    Request Was the NIH Conference Based on a
    Faulty Premise?
  • Henci Goers piece in Lamaze e-news (June 2006)
  • Rona McCandlishs article in MIDWIFERY (v.22,
    2006) Meeting maternal request for Cesarean
    section paving the road to hell?

20
Possible consequences of these Recommendations
  • An increasing trend towards considering cesarean
    birth as a normal birth with benefits/harms on
    par with vaginal birth
  • Misleading coverage in the media
  • Continued distortion of the concept of womens
    right to choose

21
  • Maternal mortality and severe morbidity
    associated with low-risk planned cesarean
    delivery versus planned vaginal delivery at term
  • Liu et al. CMAJ Feb 2007
  • (This study used a breech group as a surrogate
    for an elective cesarean group)

22
  • Among healthy women in the study
  • 27.3 per 1,000 women in the planned cesarean
    group (breech births) had severe complications
    (such as major infections or blood clots) vs. 9
    per 1,000 women in the planned vaginal group

23
  • From the CMAJ commentary
  • This study provides additional support to a
    growing body of evidence suggesting that primary
    elective cesarean birth may place both mother and
    newborn at greater risk for adverse outcomes than
    planned vaginal birth

24
  • COSMETIC SURGERY is the fastest growing medical
    specialty in the U.S.

25
  • Breast implants solely for cosmetic purposes
    are increasing in popularity despite substantial
    risks associated with both silicone and saline
    implants.

26
  • See the booklet prepared by the US Food and Drug
    Administration for photographs and descriptions
    of adverse implant outcomes such as
    disfigurement, capsular contracture (when the
    breast becomes hard and misshapen), and
    deflation
  • www.fda.gov/cdrh/breastimplants)

27
Sample Photo from Implant Makers Website
28
Photo of Capsular ContractureFrom FDA Booklet
29
This is the same 27-year old woman after her
painful implants were removed
30
Necrosis in mastectomy patient with implants for
one week
31
After removal of one womans leaking silicone
implants
32
  • According to the American Society for Aesthetic
    Plastic Surgery, 364,610 women got breast
    implants in 2005. The number was up 9 percent
    from 2004.

33
  • It's like being set free, from being trapped in
    a bad body, to being set free in a nice body.
  • From More women having mommy makeovers by
    Kim BaerThe Free Lance-Star
  • (Fredericksburg, VA) March 13, 2007

34
  • A survey by the American Society of Plastic
    Surgeons showed that nearly 40 percent of plastic
    surgery patients believe they should have been
    more proactive in learning about potential side
    effects and complications before surgery.

35
There are over-the counter creams and lotions.
And then theres Botox Cosmetic. My doctor says
theyre just not the same. She said only
prescription Botox is approved by the FDA to
treat the frown lines between your brows
36
  • A large coalition of groups
  • See www.safecosmetics.org
  • Skin Deep a report of the Environmental
    Working Group, helps consumers and workers to
    better protect themselves from known or suspected
    carcinogens and reproductive toxins.

37
In October 2005, Governor Schwarzenegger signed
the Safe Cosmetics Act into California law. As of
January 1, 2007, cosmetics manufacturers in the
state will be required to disclose any product
ingredients that cause cancer or birth defects. 
38
Harmful Substances to Avoid
  • Para-phenylenediamine, a chemical found in some
    dark hair dyes (may increase risk for bladder
    cancer in humans)
  • Phthalates, typically used as a solvent and
    plastic softener and also found in many shampoos
    and other hair products, cosmetics, deodorants
    and nail polish (has been linked to cancer and to
    birth defects of the male reproductive system).
    To learn more, go to www.nottoopretty.org.

39
  • To avoid (continued)
  • Talc, in talcum powder (has been linked to a 60
    increase in the risk for ovarian cancer in women
    who use it in the genital area).
  • Propylene glycol, an ingredient found in some
    moisturizing products and skin creams (may damage
    the kidneys and liver).

40
What to do to minimize risk
  • Read labels carefully and choose all-natural
    alternatives, such as products made with olive
    oil, safflower oil or oatmeal, whenever possible.

41
  • Direct-to-Consumer Advertising of Prescription
    Drugs
  • Misleading Ads and How They Hurt Us

42
The Public Gets Misinformation
  • Benefits are often overstated, while risks are
    understated
  • FDA warning letters are issued after the ads run
  • Corrective ads are rarely required
  • Withdrawal of an ad is the only penalty

43
  • Ads are geared primarily to selling more drug
    product, not educating the user
  • The ads work the most highly advertised drugs,
    accompanied by promotional campaigns geared to
    physicians, sell extremely well

44
  • Top selling drug in the world?

45
  • Lipitor (Pfizer)
  • (with more than 13 billion dollars in sales in
    2005)

46
  • Drugs can be quite useful, but Pills for
    Prevention may not be the best approach.

47
  • Important to promote a view of public health
    that stresses primary prevention identifying
    and eliminating disease-causing agents in our
    food, water, and air.

48
  • Precautionary Principle of Public Health
  • When an activity raises threats of harm to the
    environment or human health, precautionary
    measures should be taken even if some cause and
    effect relationships are not fully established.
  • Science and Environmental Health Network
    www.sehn.org

49
  • Consider the example of an ad for SARAFEM
    (Prozac repackaged as a pink and purple capsule)
    at www.sarafem.com
  • (ad since removed)
  •  

50
  • Think its PMS? Think Againit could be PMDD
  • Picture of a young woman trying to zip her
    jeans (too bloated?) picture of another woman
    seemingly distressed
  • Then text follows

51
  • Irritability, sadness, sudden mood changes,
    tension, bloating. If you suffer from many of
    these symptoms month after month and they clearly
    interfere with your daily activities and
    relationships you could have PMDD

52
  • PMDD, Premenstrual Dysphoric Disorder, is a
    distinct medical condition that is characterized
    by intense mood and physical symptoms right
    before your period.

53
Sarafem can help. Doctors can treat PMDD with
medication for PMDD
  • Constantly flashing, each shown consecutively
  • Mood swings---irritability---bloated feeling

54
  • Drug regulators in Europe forced Eli Lilly to
    drop PMDD as one of the approved uses for Prozac
    (Sarafem), as the data did not provide adequate
    evidence of efficacy.

55
  • Current content at this website has changed.
    Sample quote
  • Many physicians believe that Sarafem helps to
    correct the imbalance of serotonin that could
    contribute to PMDD.

56
  • Antidepressants increased the risk of suicidal
    thinking and behavior in children and teenagers
    with depression and other psychiatric disorders.
  • Patients starting therapy should be observed
    closely for worsening depression symptoms,
    suicidal thoughts or behavior, or unusual changes
    in behavior.
  • Sarafem is not approved for use in patients
    under the age of 18.

57
(No Transcript)
58
  • The ad was misleading because it mixed
    relative risk with absolute risk, noting, for
    example, the following
  • 44 fewer breast cancers in women taking
    tamoxifen vs. women taking a placebo
  • But there was NO mention of the following
    relative risk a 252 increased risk of
    endometrial cancer

59
  • The ad also noted a risk of serious problems
    such as endometrial cancer or blood clots at
    only 1-2 (absolute risk)
  • But left out was any mention that women have
    only a 1.8 chance of benefiting from the drug
    (absolute benefit)

60
  • Unpaid advertising also a problem
  • Parade magazine, for example, put model Lauren
    Hutton on its cover for a piece on celebrity
    beauty tips, and quoted her saying her "No. 1
    secret is estrogen. Its good for your moods,
    its good for your skin. If I had to choose
    between all my creams and makeup for feeling and
    looking good, Id take the estrogen.

61
  • The article didnt mention that Hutton was a
    paid spokesperson for Wyeth Ayerst, and that she
    appeared in their ads. It also didnt mention
    that Hutton's claims for estrogen's benefits were
    not backed up by valid scientific evidence.

62
  • Female Sexual Dysfunction
  • Is this a serious problem requiring primarily
    biomedical solutions, or is a different approach
    most often called for?

63
In 1999, Pfizer consultants analyzed one question
from a 1994 survey and produced an overly
simplistic conclusion that 43 of American
women suffer from sexual dysfunction
64
  • Idea Marketing
  • A disease awareness campaign is now building a
    drug market usingthe 43 FSD statistic.
  • (Slide Courtesy of Leonore Tiefer)

65
To promote The Hunt for the
Pink Viagra(Slide Courtesy of Leonore
Tiefer)
66
  • For more information about female sexual
    problems, see the website of the Campaign for a
    New View of Womens Sexual Problems
  • www.fsd-alert.org

67
Menopause
Every day 5,000 women in the U.S. enter
menopause, the so-called change of life
68
What do we think about menopause?
  • Some women see it as the end of sex or the end
    of youth
  • Some see a passport to freedom (no fear of
    getting pregnant, no messing with pads and
    tampons, no more shoulds about how one needs to
    look)
  • Possibly more time for oneself

69
What influences our thinking?
  • Media messages that worship youth, thinness, and
    suggest its not OK to grow old
  • Conversations with other women about their actual
    experiences with menoapuse

70
Opportunities for Medicalization
  • Less/no interest in sex
  • Hot flashes/vaginal dryness and loss of
    elasticity
  • Loss of bone density

71
  • More spreading waistlines and sagging skin
  • Memory problems
  • Depression
  • Problems with sleep

72
  • Approaches to dealing with sleep problems other
    than prescription sleeping drugs such as Ambien
    and Lunesta
  • Yoga/exercise
  • Avoiding caffeine
  • Deep breathing/massage at bedtime from a partner
  • Sleep in a cool room

73
Non-hormonal approaches to dealing with hot
flashes
  • Wear layered clothing
  • Use fans
  • Put palms or bare feet on a cold surface
  • Cold pack under the pillow
  • Exercise, yoga, deep breathing
  • Less caffeine, less spicy foods, less alcohol
    (especially red wine)

74
Removing health ovaries
  • US federal data from the late 1990s
  • 78 of women 45-64 who have had a hysterectomy
    also had healthy ovaries removed (even though
    most were not at particular risk of developing
    ovarian cancer).

75
  • Latest research shows that for women without a
    family history of ovarian cancer there is a
    significant reduction in death from heart disease
    and complications of osteoporosis IF THE OVARIES
    ARE KEPT, especially until the age of 65.

76
  • KEY FINDINGS OF WILLIAM PARKER et al study in
    2005
  • For 10,000 women 50-54 yrs old who undergo a
    hysterectomy with oophorectomy, there will be 47
    fewer cases of ovarian cancer by the time these
    women reach 80 when compared with a similar group
    who keep their ovaries.

77
  • BUT the oophorectomy group will suffer 838
    additional deaths from coronary heart disease as
    well as 158 more deaths from hip fractures.
    (Numbers reflect women who do NOT have estrogen
    therapy there is a smaller survival benefit to
    keeping the ovaries in women taking estrogen.)

78
  • Ads for bone density screening now pitched at
    women around 50 yrs of age
  • Creation of the T score and a new
    classification called osteopenia (for -1 to -2.5
    scores)
  • Merck stopped by the FDA from using the claim
    menopause is the single most important cause of
    osteoporosis in their ads

79
Cloning, Stem Cells and Inheritable Genetic
ModificationSpecial case of embryo cloning
(somatic cell nuclear transfer)
80
Research the promises and the challenges
  • Balancing our interest in developing new medical
    therapies with the need to protect research
    subjects and the need to preserve values of
    social justice and equity
  • Developing technologies that will be accessible
    to most

81
  • Often Ignored Concerns
  • Risks to womens health
  • Gateway to designer babies
  • Unethical experimentation on humans
  • Fueling of a new eugenics movement

82
Risks to Womens Health from Research Cloning
  • Also known as therapeutic cloning or somatic
    cell nuclear transfer (SCNT), SCNT requires the
    collection of many eggs from women willing to
    undergo egg extraction procedures.

83
Some Concerns about Multiple Egg Extraction
  • Use of leuprolide acetate (Lupron), a GnRH
    agonist, to shut down the ovaries, is not
    FDA-aproved for this purpose (Antagon, a GnRH
    antagonist that is also used, is approved for
    this use.)
  • Use of drugs that hyper-stimulate the ovaries to
    produce multiple follicles

84
  • As Spring of 1999, US Food and Drug
    Administration (FDA) had received 4228 reports of
    adverse drug events from women using Lupron.
    325 of the adverse events for women reported to
    the FDA resulted in hospitalization, and
    additionally, 25 deaths were reported.

85
The Research Cloning Debate
  • The most vocal participants have been
  • Anti-choice conservatives opposed to the
    destruction of embryos, who favor a permanent ban
  • Biomedical researchers and their allies, who are
    wary of or opposed to regulatory oversight

86
Good Resources
  • National Womens Health Network (DC)
  • Breast Cancer Action (SF)
  • Collaborative on Health and the Environment
  • Science and Environmental Health Network
  • Silent Spring Institute (Newton, MA)
  • Teen Voices magazine (Boston)
  • Center for Medical Consumers (NYC)
  • Canadian Womens Health Network (CWHN)
  • www.ourbodiesourselves.org

87
(No Transcript)
88
  • www.ourbodiesourselves.org
  • May 2005

89
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com